Nifty
:
15783.20
Sensex
:
52538.14
-86.05 (-0.54%)
-234.91 (-0.45%)
Nifty
Sensex
:
:
15783.20
52538.14
-86.05 (-0.54%)
-234.91 (-0.45%)

Lincoln Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Global

Rating :
58/99

BSE: 531633 | NSE: LINCOLN

NSE BSE
310.80
15-Jun-2021
  • Open
  • High
  • Low
  • Previous Close
  •  292.70
  •  313.00
  •  292.70
  •  295.65
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  527814
  •  1618.60
  •  337.95
  •  154.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 622.90
  • 10.01
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 613.39
  • 0.48%
  • 1.66

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 37.26%
  • 10.29%
  • 42.89%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 9.56%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.15
  • -0.69
  • 2.34

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 21.27
  • 10.09
  • 4.61

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 28.56
  • 16.78
  • 14.11

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.00
  • 9.45
  • 8.06

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.49
  • 1.69
  • 1.41

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.76
  • 7.02
  • 5.75

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Net Sales
79.58
78.47
1.41%
114.75
98.52
16.47%
126.06
112.69
11.86%
103.79
96.81
7.21%
Expenses
64.34
69.85
-7.89%
94.74
85.33
11.03%
96.30
88.01
9.42%
81.63
77.77
4.96%
EBITDA
15.24
8.62
76.80%
20.00
13.19
51.63%
29.76
24.68
20.58%
22.17
19.05
16.38%
EBIDTM
19.16%
10.98%
17.43%
13.39%
23.61%
21.90%
21.36%
19.67%
Other Income
2.54
4.19
-39.38%
0.73
3.04
-75.99%
0.60
2.52
-76.19%
1.80
1.29
39.53%
Interest
0.57
-0.56
-
0.39
1.35
-71.11%
-0.08
0.58
-
0.67
0.65
3.08%
Depreciation
1.89
1.83
3.28%
1.90
1.88
1.06%
1.90
1.77
7.34%
1.88
1.85
1.62%
PBT
15.31
11.53
32.78%
18.44
12.99
41.96%
28.55
24.85
14.89%
21.41
17.85
19.94%
Tax
2.73
2.59
5.41%
4.96
2.07
139.61%
7.63
5.92
28.89%
6.15
5.17
18.96%
PAT
12.58
8.94
40.72%
13.48
10.92
23.44%
20.92
18.93
10.51%
15.26
12.68
20.35%
PATM
15.81%
11.39%
11.75%
11.08%
16.60%
16.80%
14.70%
13.09%
EPS
6.29
4.47
40.72%
6.74
5.46
23.44%
10.46
9.46
10.57%
7.63
6.33
20.54%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
424.18
386.49
366.15
360.61
360.26
400.15
266.07
210.49
194.70
187.58
176.51
Net Sales Growth
9.75%
5.56%
1.54%
0.10%
-9.97%
50.39%
26.41%
8.11%
3.80%
6.27%
 
Cost Of Goods Sold
197.73
138.15
135.66
156.44
202.90
254.64
161.12
123.72
113.96
111.61
105.50
Gross Profit
226.45
248.34
230.49
204.18
157.35
145.50
104.96
86.77
80.74
75.97
71.01
GP Margin
53.38%
64.26%
62.95%
56.62%
43.68%
36.36%
39.45%
41.22%
41.47%
40.50%
40.23%
Total Expenditure
337.01
320.95
298.91
308.30
313.52
359.62
240.47
190.42
179.22
174.08
166.98
Power & Fuel Cost
-
8.18
7.21
6.82
5.92
5.68
4.27
3.40
2.12
0.73
0.68
% Of Sales
-
2.12%
1.97%
1.89%
1.64%
1.42%
1.60%
1.62%
1.09%
0.39%
0.39%
Employee Cost
-
58.65
51.90
51.15
37.59
28.83
17.87
18.57
17.71
16.52
14.30
% Of Sales
-
15.18%
14.17%
14.18%
10.43%
7.20%
6.72%
8.82%
9.10%
8.81%
8.10%
Manufacturing Exp.
-
64.05
60.71
51.73
29.44
35.81
25.98
19.10
17.54
16.91
16.31
% Of Sales
-
16.57%
16.58%
14.35%
8.17%
8.95%
9.76%
9.07%
9.01%
9.01%
9.24%
General & Admin Exp.
-
21.30
20.98
17.50
14.78
20.34
18.86
15.07
13.25
13.36
7.77
% Of Sales
-
5.51%
5.73%
4.85%
4.10%
5.08%
7.09%
7.16%
6.81%
7.12%
4.40%
Selling & Distn. Exp.
-
26.79
20.02
21.24
19.91
10.10
9.42
8.42
13.22
13.66
22.18
% Of Sales
-
6.93%
5.47%
5.89%
5.53%
2.52%
3.54%
4.00%
6.79%
7.28%
12.57%
Miscellaneous Exp.
-
3.83
2.43
3.44
2.97
4.22
2.95
2.13
1.43
1.28
22.18
% Of Sales
-
0.99%
0.66%
0.95%
0.82%
1.05%
1.11%
1.01%
0.73%
0.68%
0.14%
EBITDA
87.17
65.54
67.24
52.31
46.74
40.53
25.60
20.07
15.48
13.50
9.53
EBITDA Margin
20.55%
16.96%
18.36%
14.51%
12.97%
10.13%
9.62%
9.53%
7.95%
7.20%
5.40%
Other Income
5.67
11.04
5.63
5.45
2.78
7.36
7.19
2.49
6.40
3.36
3.30
Interest
1.55
2.02
4.00
5.41
6.66
9.96
8.38
6.97
7.84
7.60
4.98
Depreciation
7.57
7.33
6.68
6.11
5.51
4.87
4.57
3.53
2.65
1.93
1.67
PBT
83.71
67.23
62.19
46.25
37.33
33.07
19.85
12.07
11.38
7.33
6.18
Tax
21.47
15.77
13.46
11.60
9.20
9.27
4.80
1.89
1.85
2.20
2.01
Tax Rate
25.65%
23.46%
21.64%
25.08%
24.65%
28.03%
24.18%
15.66%
16.26%
30.01%
32.52%
PAT
62.24
51.44
48.71
34.62
28.12
23.68
15.01
10.65
9.66
5.12
4.17
PAT before Minority Interest
62.22
51.47
48.74
34.65
28.13
23.80
15.04
10.18
9.53
5.13
4.17
Minority Interest
-0.02
-0.03
-0.03
-0.03
-0.01
-0.12
-0.03
0.47
0.13
-0.01
0.00
PAT Margin
14.67%
13.31%
13.30%
9.60%
7.81%
5.92%
5.64%
5.06%
4.96%
2.73%
2.36%
PAT Growth
20.92%
5.60%
40.70%
23.12%
18.75%
57.76%
40.94%
10.25%
88.67%
22.78%
 
EPS
31.12
25.72
24.36
17.31
14.06
11.84
7.51
5.33
4.83
2.56
2.09

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
313.09
269.34
224.22
192.38
140.52
111.31
98.81
89.30
80.78
76.82
Share Capital
20.00
20.00
20.00
20.00
16.31
16.31
16.31
16.31
16.31
16.31
Total Reserves
293.09
249.34
204.22
172.38
116.65
95.00
82.50
72.99
64.47
60.50
Non-Current Liabilities
42.85
28.43
24.94
31.75
33.74
33.14
26.18
25.14
22.37
11.22
Secured Loans
0.85
1.69
6.93
12.38
23.62
15.27
16.20
14.41
12.33
2.54
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
10.21
3.04
2.66
1.97
1.57
Long Term Provisions
32.51
17.49
7.19
9.98
0.00
0.00
0.00
0.00
0.00
0.00
Current Liabilities
80.32
100.37
113.48
99.42
100.34
114.47
131.05
118.26
104.86
77.24
Trade Payables
51.24
44.01
43.42
32.46
30.38
45.31
66.51
47.51
42.05
22.63
Other Current Liabilities
9.13
11.11
11.11
12.77
15.10
11.52
14.15
15.57
16.25
12.25
Short Term Borrowings
3.83
30.09
48.55
45.04
52.62
50.67
48.46
54.90
46.56
40.35
Short Term Provisions
16.11
15.16
10.41
9.15
2.24
6.97
1.92
0.27
0.00
2.01
Total Liabilities
436.64
398.50
362.97
323.85
274.79
261.85
259.75
236.88
212.31
165.28
Net Block
122.72
120.91
116.58
102.71
98.47
65.62
65.07
64.94
37.74
27.96
Gross Block
146.70
138.11
127.65
108.16
120.89
87.50
82.22
78.82
49.07
36.70
Accumulated Depreciation
23.98
17.21
11.08
5.45
22.42
21.88
17.15
13.89
11.33
8.74
Non Current Assets
173.91
159.43
136.08
134.27
127.83
80.64
110.69
113.67
90.73
45.38
Capital Work in Progress
0.04
2.10
0.29
6.63
2.73
2.55
2.37
2.37
13.51
4.14
Non Current Investment
0.09
0.09
0.09
0.09
0.01
0.01
0.41
0.41
0.41
0.00
Long Term Loans & Adv.
51.02
36.01
18.79
24.48
26.62
12.47
42.84
45.95
39.08
13.28
Other Non Current Assets
0.03
0.33
0.34
0.36
0.00
0.00
0.00
0.00
0.00
0.01
Current Assets
262.73
239.08
226.88
189.58
146.98
181.20
149.06
123.21
121.58
119.90
Current Investments
34.22
18.07
10.97
10.25
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
47.40
36.23
45.41
37.31
27.48
21.82
23.84
19.33
21.41
26.07
Sundry Debtors
101.34
122.47
109.44
90.67
80.53
119.01
89.04
74.79
65.37
40.08
Cash & Bank
14.58
7.58
14.59
11.68
12.66
11.51
10.45
15.15
16.86
13.14
Other Current Assets
65.20
1.10
1.29
0.66
26.31
28.86
25.73
13.94
17.94
40.61
Short Term Loans & Adv.
64.09
53.64
45.18
39.02
26.26
28.86
25.73
13.94
17.94
40.61
Net Current Assets
182.41
138.71
113.40
90.16
46.63
66.73
18.01
4.95
16.72
42.66
Total Assets
436.64
398.51
362.96
323.85
274.81
261.84
259.75
236.88
212.31
165.28

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
75.42
52.84
26.63
25.04
44.80
24.56
4.64
-15.60
11.87
-34.26
PBT
67.23
62.19
46.25
37.33
33.07
19.85
12.07
9.53
5.13
8.24
Adjustment
8.66
9.30
11.64
10.70
13.75
10.68
12.75
8.96
14.32
7.27
Changes in Working Capital
14.33
-1.12
-22.00
-13.24
4.80
-2.50
-17.56
-32.36
-6.38
-48.08
Cash after chg. in Working capital
90.22
70.38
35.88
34.79
51.62
28.02
7.26
-13.87
13.07
-32.58
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-14.81
-17.53
-9.25
-9.75
-6.82
-3.46
-2.62
-1.73
-1.20
-1.68
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-30.88
-18.19
-11.77
-25.48
-41.79
6.52
1.45
-16.27
-27.23
-10.89
Net Fixed Assets
-5.59
-11.52
-12.45
4.05
-29.04
-4.21
-0.95
-2.89
-4.61
-12.04
Net Investments
-14.20
-7.10
-2.72
-16.01
-7.34
-1.43
0.00
0.00
-11.16
0.00
Others
-11.09
0.43
3.40
-13.52
-5.41
12.16
2.40
-13.38
-11.46
1.15
Cash from Financing Activity
-37.76
-35.77
-11.41
0.30
-3.42
-32.04
-10.51
29.30
16.19
45.06
Net Cash Inflow / Outflow
6.77
-1.11
3.45
-0.14
-0.41
-0.96
-4.42
-2.57
0.82
-0.09
Opening Cash & Equivalents
5.46
6.57
3.12
3.26
3.75
4.82
9.39
11.97
11.53
11.62
Closing Cash & Equivalent
12.23
5.46
6.57
3.12
3.43
3.87
4.97
9.39
12.36
11.53

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
156.54
134.67
112.11
96.19
81.52
68.24
60.58
54.75
49.53
47.10
ROA
12.33%
12.80%
10.09%
9.40%
8.87%
5.77%
4.10%
4.25%
2.72%
3.02%
ROE
17.67%
19.75%
16.63%
17.29%
19.49%
14.32%
10.83%
11.21%
6.51%
6.41%
ROCE
22.30%
22.50%
19.05%
18.51%
21.18%
15.91%
11.48%
12.21%
10.94%
10.97%
Fixed Asset Turnover
2.81
2.84
3.07
3.19
3.90
3.20
2.67
3.10
4.45
5.60
Receivable days
102.22
112.23
100.99
85.52
89.69
139.97
139.16
128.96
100.92
72.36
Inventory Days
38.19
39.51
41.74
32.36
22.16
30.72
36.67
37.48
45.44
49.66
Payable days
56.60
57.26
47.62
37.21
40.22
92.31
115.76
98.21
75.46
45.35
Cash Conversion Cycle
83.81
94.48
95.11
80.67
71.63
78.37
60.06
68.23
70.90
76.67
Total Debt/Equity
0.02
0.12
0.27
0.34
0.59
0.69
0.69
0.85
0.86
0.60
Interest Cover
34.32
16.56
9.55
6.60
4.32
3.37
2.73
2.45
1.96
2.24

Annual Reports:

FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013
FY 2012
FY 2011

News Update:


No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.